Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis
Open Access
- 1 September 2014
- journal article
- research article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 9 (9), 1324-1331
- https://doi.org/10.1097/jto.0000000000000250
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Bringing the genomic landscape of small-cell lung cancer into focusNature Genetics, 2012
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerNature Genetics, 2012
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancerNature Genetics, 2012
- Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-SmokersCell, 2012
- Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsiesNature Medicine, 2012
- KIF5B-RET fusions in lung adenocarcinomaNature Medicine, 2012
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Novel strategies for the treatment of small-cell lung carcinomaNature Reviews Clinical Oncology, 2011
- Phase II Study of Everolimus (RAD001) in Previously Treated Small Cell Lung CancerClinical Cancer Research, 2010